조소연 교수 연구실
article|
bronze
·인용수 15
·2023
1313MO Safety and preliminary efficacy of AZD7789, a bispecific antibody targeting PD-1 and TIM-3, in patients (pts) with stage IIIB–IV non-small-cell lung cancer (NSCLC) with previous anti-PD-(L)1 therapy
Benjamin Besse, Antoine Italiano, Sophie Cousin, G. Ruiter, Enriqueta Felip, Eduardo Castañón Álvarez, Suresh S. Ramalingam, Christian Rolfo, David R. Spigel, Diana Andrew, Soyun Cho, Teresa Collins, Aaron R. Hansen, George Hawkins, Raffael Kurek, Natalia Ceaicovscaia, Michele Petruzzelli, Emma Dean, Adrian G. Sacher
IF 65.4Annals of Oncology
키워드
MedicineInternal medicineDiscontinuationGastroenterologyAdverse effectOncologyPharmacokineticsAntibodyImmunology